Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study

Treatment of relapsed/refractory multiple myeloma (RRMM) aims to prolong survival while maintaining health-related quality of life (HRQoL) by managing disease-related symptoms and complications—one of the most frequent and debilitating being bone pain. In the ELOQUENT-2 study (NCT01239797), which ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Cella, David, McKendrick, Jan, Kudlac, Amber, Palumbo, Antonio, Oukessou, Abderrahim, Vij, Ravi, Zyczynski, Teresa, Davis, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208683/
https://www.ncbi.nlm.nih.gov/pubmed/30178193
http://dx.doi.org/10.1007/s00277-018-3469-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208683/
https://www.ncbi.nlm.nih.gov/pubmed/30178193
http://dx.doi.org/10.1007/s00277-018-3469-4

Ejemplares similares